drugset / Trial / NCT01911637
Safety Study of Single Oral Doses of VBY-036 in Healthy Volunteers (VBY036P1A)
RandomizedSingle-groupTriple-blindTreatment
Summary
VBY-036 may treat or prevent nerve pain. This study aims to find the highest safe and tolerable single dose of VBY-036 in healthy volunteers. Volunteers are randomly selected to receive one dose of either a placebo or VBY-036 (10, 30, 100, 300, 600 or 900 mg).
Timeline
- Start
- 2013-05
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VBY-036 | Unknown | 10 mg | — |
| Subject | VBY-036 | Unknown | 30 mg | — |
| Subject | VBY-036 | Unknown | 100 mg | — |
| Subject | VBY-036 | Unknown | 300 mg | — |
| Subject | VBY-036 | Unknown | 600 mg | — |
| Subject | VBY-036 | Unknown | 900 mg | — |
Indications
No indication recorded.